Literature DB >> 31870702

Efficacy of Sucrose in Reducing Pain during Immunization among 10- to 18-Month-Old Infants and Young Children: A Randomized Controlled Trial.

Manal Kassab1, Basima Almomani2, Khawla Nuseir3, Ala A Alhouary4.   

Abstract

PURPOSE: Sucrose is recommended to reduce pain associated with vaccination in neonates. However, research results concerning its effectiveness in infants and young children are inconclusive. This study aims to determine the efficacy of sucrose administration in reducing pain during immunization in 10- to 18-month-old infants and young children as assessed by behavioral pain parameters, crying time, and saliva substance (P) concentration. DESIGN AND METHODS: This was a double-blind, randomized controlled trial and included healthy infants and young children undergoing their 10- to 18-month immunization. Behavioral pain outcome was measured during, and shortly after the last injection. The infant's pain was also measured by a salivary test using substance (P), and videotaping of crying time.
RESULTS: The study results indicate that, compared with a placebo group, the sucrose group had significantly less pain post-immunization (F (1,129) = 1.72, p = 0.001). Moreover, substance (P) was lower in the intervention group post-immunization, and it could be considered a good predictor of pain reduction associated with immunization.
CONCLUSIONS: Sucrose administration during immunization injection helps in reducing pain, which is one of the most critical factors affecting compliance with the immunization schedule. Substance (P) measurement can be used as a predictor of immunization pain level in 10- to 18-month-old infants and young children. PRACTICE IMPLICATIONS: Sucrose is an effective method to reduce needle pain during immunization; therefore, healthcare providers should administer sucrose as a pain relief intervention in the immunization clinical setting.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Immunization; Infants and young children; Pain; Substance (P)

Year:  2019        PMID: 31870702     DOI: 10.1016/j.pedn.2019.11.010

Source DB:  PubMed          Journal:  J Pediatr Nurs        ISSN: 0882-5963            Impact factor:   2.145


  2 in total

1.  Efficacy of topical lidocaine-prilocaine (EMLA®) for management of infant pain during pneumococcal vaccination: A randomized controlled trial.

Authors:  Beatrice Olsson Duse; Ylva Sporrong; Marco Bartocci; Karin Skoglund
Journal:  Paediatr Neonatal Pain       Date:  2021-12-24

2.  The Effect of Breastfeeding Versus Sensorial Saturation on Infants' Behavioral Responses of Pain following Pentavalent Vaccination on 4 and 6 Month Old Infants: A Randomized Controlled Clinical Trial Study.

Authors:  Zohreh Karimi; Narges Kazemi Karani; Ebrahim Momeni; Ardashir Afrasiabifar
Journal:  Int J Community Based Nurs Midwifery       Date:  2022-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.